{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:44:00Z","timestamp":1774971840498,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-025-01161-7","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:55:13Z","timestamp":1768384513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Upregulated ARMCX1 suppresses nasopharyngeal carcinoma progression by promoting TRIM21-mediated \u03b2-catenin degradation"],"prefix":"10.1007","volume":"49","author":[{"given":"Zhe","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enqing","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiankang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoou","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houkuang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangfan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"1161_CR1","doi-asserted-by":"crossref","unstructured":"M.F. Ji et al., Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China. Nat. Commun. 16, 5940 (2025)","DOI":"10.1038\/s41467-025-60999-5"},{"key":"1161_CR2","doi-asserted-by":"crossref","unstructured":"W.R. Luo, Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal \u201cunity of ecology and evolution\u201d pathological ecosystem. Theranostics 13, 1607\u20131631 (2023)","DOI":"10.7150\/thno.82690"},{"key":"1161_CR3","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s11864-023-01101-3","volume":"24","author":"J.J.J.-V. Whaley","year":"2023","unstructured":"J.J. Juarez-Vignon Whaley et al., Recurrent\/Metastatic nasopharyngeal carcinoma treatment from present to future: Where are we and Where are we Heading? Curr. Treat. Options Oncol. 24, 1138\u20131166 (2023)","journal-title":"Curr. Treat. Options Oncol."},{"key":"1161_CR4","first-page":"47","volume":"10","author":"M. Serena","year":"2016","unstructured":"M. Serena et al., Function of Armcx3 and Armc10\/SVH genes in the regulation of progenitor proliferation and neural differentiation in the chicken spinal cord. Front Cell. Neurosci. 10, 47 (2016)","journal-title":"Front Cell. Neurosci."},{"key":"1161_CR5","doi-asserted-by":"crossref","unstructured":"Z.M. Mou et al., The armadillo repeat-containing protein, ARMCX3, physically and functionally interacts with the developmental regulatory factor Sox10. J. Biol. Chem. 284, 13629\u201313640 (2009)","DOI":"10.1074\/jbc.M901177200"},{"key":"1161_CR6","doi-asserted-by":"crossref","unstructured":"D.F. Lu et al., Armcx1 attenuates secondary brain injury in an experimental traumatic brain injury model in male mice by alleviating mitochondrial dysfunction and neuronal cell death. Neurobiol. Dis. 184, 106228 (2023)","DOI":"10.1016\/j.nbd.2023.106228"},{"key":"1161_CR7","doi-asserted-by":"crossref","unstructured":"Q.Y. Li et al., Armcx1 reduces neurological damage via a mitochondrial Transport pathway involving Miro1 after traumatic brain injury. J Neurosci. 545, 111\u2013124 (2024)","DOI":"10.1016\/j.neuroscience.2024.03.009"},{"key":"1161_CR8","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.neuron.2016.10.060","volume":"92","author":"R. Cartoni","year":"2016","unstructured":"R. Cartoni et al., The mammalian-specific protein Armcx1 regulates mitochondrial Transport during axon regeneration. Neuron 92, 1294\u20131307 (2016)","journal-title":"Neuron"},{"key":"1161_CR9","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/j.1349-7006.2012.02300.x","volume":"103","author":"H. Iseki","year":"2012","unstructured":"H. Iseki et al., ALEX1 suppresses colony formation ability of human colorectal carcinoma cell lines. Cancer Sci. 103, 1267\u20131271 (2012)","journal-title":"Cancer Sci."},{"key":"1161_CR10","doi-asserted-by":"crossref","unstructured":"Y. Gao et al., ALEX1 regulates proliferation and apoptosis in breast cancer cells. Asian Pac. J. Cancer Prev. 16, 3293\u20133299 (2015)","DOI":"10.7314\/APJCP.2015.16.8.3293"},{"key":"1161_CR11","doi-asserted-by":"crossref","unstructured":"L. Pang et al., ALEX1, a novel tumor suppressor gene, inhibits gastric cancer metastasis via the PAR-1\/Rho GTPase signaling pathway. J. Gastroenterol. 53, 71\u201383 (2017)","DOI":"10.1007\/s00535-017-1329-y"},{"key":"1161_CR12","doi-asserted-by":"crossref","unstructured":"Z. Hu et al., ARMCX1 inhibits lung adenocarcinoma progression by recruiting FBXW7 for c-Myc degradation. Biol. Direct 19, 82 (2024)","DOI":"10.1186\/s13062-024-00532-8"},{"key":"1161_CR13","doi-asserted-by":"crossref","unstructured":"Y.Y. Ruan et al., Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma. J. Clin. Invest. 122, 2554\u20132566 (2012)","DOI":"10.1172\/JCI58488"},{"key":"1161_CR14","doi-asserted-by":"crossref","unstructured":"Q.L. Tang et al., m(6)A modification-dependent upregulation of WNT2 facilitates M2-like macrophage polarization and perpetuates malignant progression of nasopharyngeal carcinoma. Oncogene 44, 2730\u20132745 (2025)","DOI":"10.1038\/s41388-025-03452-7"},{"key":"1161_CR15","doi-asserted-by":"crossref","unstructured":"H.H. Wang et al., Targeting EGFR-binding protein SLC7A11 enhancing antitumor immunity of T cells via inducing MHC-I antigen presentation in nasopharyngeal carcinoma. Cell. Death Dis. 16(21), (2025)","DOI":"10.1038\/s41419-024-07327-9"},{"key":"1161_CR16","doi-asserted-by":"crossref","unstructured":"J.Z. Li et al., Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma. Cell. Death Dis. 15(35), (2024)","DOI":"10.1038\/s41419-024-06429-8"},{"key":"1161_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ijc.31023","volume":"142","author":"G. Fountzilas","year":"2017","unstructured":"G. Fountzilas et al., Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe. Int. J. Cancer 142, 66\u201380 (2017)","journal-title":"Int. J. Cancer"},{"key":"1161_CR18","doi-asserted-by":"crossref","unstructured":"W.Q. Chong et al., Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial. Lancet Oncol. 26, 175\u2013186 (2025)","DOI":"10.1016\/S1470-2045(24)00677-6"},{"key":"1161_CR19","doi-asserted-by":"crossref","unstructured":"Q. Zhu et al., EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma. J. Transl. Med. 22, 1111 (2024)","DOI":"10.1186\/s12967-024-05822-3"},{"key":"1161_CR20","doi-asserted-by":"publisher","first-page":"e189207","DOI":"10.1172\/JCI189207","volume":"135","author":"B.E. Warner","year":"2025","unstructured":"B.E. Warner, K.H. Shair, High IgG titers against EBV glycoprotein 42 correlate with lower risk of nasopharyngeal carcinoma. J. Clin. Invest. 135, e189207 (2025)","journal-title":"J. Clin. Invest."},{"key":"1161_CR21","doi-asserted-by":"publisher","first-page":"e03647","DOI":"10.1002\/advs.202503647","volume":"12","author":"J.H. Yang","year":"2025","unstructured":"J.H. Yang et al., DDAH1 promotes cisplatin chemoresistance in patients with locally advanced nasopharyngeal carcinoma via the EGFR-JAK2-STAT3 pathway. Adv. Sci. 12, e03647 (2025)","journal-title":"Adv. Sci."},{"key":"1161_CR22","doi-asserted-by":"crossref","unstructured":"G.D. Jia et al., Endoplasmic reticulum-localized circular RNA FAM13B restrains nasopharyngeal carcinoma lymphatic metastasis through downregulating XBP1. J. Exp. Clin. Cancer Res. 44, 223 (2025)","DOI":"10.1186\/s13046-025-03468-7"},{"key":"1161_CR23","unstructured":"W.R. Luo, Rethinking cancer. Zhonghua Zhong Liu Za Zhi 47, 463\u2013467 (2025)"},{"key":"1161_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13062-024-00506-w","volume":"19","author":"X.F. Liu","year":"2024","unstructured":"X.F. Liu et al., STAU1-mediated CNBP mRNA degradation by LINC00665 alters stem cell characteristics in ovarian cancer. Biol. Direct 19, 59 (2024)","journal-title":"Biol. Direct"},{"key":"1161_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-cellbio-120319-023657","volume":"37","author":"L.V. Albrecht","year":"2021","unstructured":"L.V. Albrecht et al., Cell biology of canonical Wnt signaling. Annu. Rev. Cell. Dev. Biol. 37, 369\u2013389 (2021)","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"1161_CR26","doi-asserted-by":"crossref","unstructured":"J.Q. Liu et al., Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 7(3), (2022)","DOI":"10.1038\/s41392-021-00762-6"},{"key":"1161_CR27","doi-asserted-by":"publisher","first-page":"a007898","DOI":"10.1101\/cshperspect.a007898","volume":"5","author":"J.L. Stamos","year":"2012","unstructured":"J.L. Stamos, W.I. Weis, The \u03b2-catenin destruction complex. Cold Spring Harb. Perspect. Biol. 5, a007898 (2012)","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1161_CR28","doi-asserted-by":"crossref","unstructured":"W.R. Luo et al., Neoplastic spindle cells in nasopharyngeal carcinoma show features of epithelial-mesenchymal transition. Histopathology 61, 113\u2013122 (2012)","DOI":"10.1111\/j.1365-2559.2012.04205.x"},{"key":"1161_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41580-024-00733-z","volume":"25","author":"K.K. Youssef","year":"2024","unstructured":"K.K. Youssef, M.A. Nieto, Epithelial-mesenchymal transition in tissue repair and degeneration. Nat. Rev. Mol. Cell. Biol. 25, 720\u2013739 (2024)","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"1161_CR30","doi-asserted-by":"publisher","first-page":"1234850","DOI":"10.1126\/science.1234850","volume":"342","author":"M.A. Nieto","year":"2013","unstructured":"M.A. Nieto, Epithelial plasticity: a common theme in embryonic and cancer cells. Science 342, 1234850 (2013)","journal-title":"Science"},{"key":"1161_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2024.03.002","volume":"100","author":"A.Q. Khan","year":"2024","unstructured":"A.Q. Khan et al., Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy. Semin. Cancer Biol. 100, 1\u201316 (2024)","journal-title":"Semin. Cancer Biol."},{"key":"1161_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10555-023-10162-7","volume":"43","author":"N. Ebrahimi","year":"2024","unstructured":"N. Ebrahimi et al., Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response. Cancer Metastasis Rev. 43, 457\u2013479 (2024)","journal-title":"Cancer Metastasis Rev."},{"key":"1161_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10555-023-10141-y","volume":"43","author":"D. Singh","year":"2023","unstructured":"D. Singh, H.R. Siddique, Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance. Cancer Metastasis Rev. 43, 155\u2013173 (2023)","journal-title":"Cancer Metastasis Rev."},{"key":"1161_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.004","volume":"97","author":"X.C. Wang","year":"2023","unstructured":"X.C. Wang et al., TGF-\u03b2, EMT, and resistance to anti-cancer treatment. Semin. Cancer Biol. 97, 1\u201311 (2023)","journal-title":"Semin. Cancer Biol."},{"key":"1161_CR35","doi-asserted-by":"publisher","first-page":"102115","DOI":"10.1016\/j.arr.2023.102115","volume":"92","author":"J.L. Yang","year":"2023","unstructured":"J.L. Yang et al., Epithelial-mesenchymal transition in age-associated thymic involution: mechanisms and therapeutic implications. Ageing Res. Rev. 92, 102115 (2023)","journal-title":"Ageing Res. Rev."},{"key":"1161_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","volume":"81","author":"W.H. Xue","year":"2024","unstructured":"W.H. Xue et al., Wnt\/\u03b2-catenin-driven EMT regulation in human cancers. Cell. Mol. Life Sci. 81, 79 (2024)","journal-title":"Cell. Mol. Life Sci."},{"key":"1161_CR37","doi-asserted-by":"crossref","unstructured":"W.R. Luo et al., Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma. Int. J. Cancer 131, 1863\u20131873 (2012)","DOI":"10.1002\/ijc.27467"},{"key":"1161_CR38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41419-024-06687-6","volume":"15","author":"X.M. Ou","year":"2024","unstructured":"X.M. Ou et al., PICK1 inhibits the malignancy of nasopharyngeal carcinoma and serves as a novel prognostic marker. Cell. Death Dis. 15, 294 (2024)","journal-title":"Cell. Death Dis."},{"key":"1161_CR39","doi-asserted-by":"publisher","first-page":"216585","DOI":"10.1016\/j.canlet.2023.216585","volume":"583","author":"Q.Y. Liu","year":"2023","unstructured":"Q.Y. Liu et al., CMTM6 promotes hepatocellular carcinoma progression through stabilizing \u03b2-catenin. Cancer Lett. 583, 216585 (2023)","journal-title":"Cancer Lett."},{"key":"1161_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41419-023-05747-7","volume":"14","author":"J.N. Tang","year":"2023","unstructured":"J.N. Tang et al., USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through \u03b2-catenin stabilization. Cell. Death Dis. 14, 360 (2023)","journal-title":"Cell. Death Dis."},{"key":"1161_CR41","doi-asserted-by":"publisher","first-page":"156156","DOI":"10.1016\/j.phymed.2024.156156","volume":"135","author":"Z.H. Ren","year":"2024","unstructured":"Z.H. Ren et al., Yes-associated protein indispensably mediates hirsutine-induced inhibition on cell growth and Wnt\/\u03b2-catenin signaling in colorectal cancer. Phytomedicine 135, 156156 (2024)","journal-title":"Phytomedicine"},{"key":"1161_CR42","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41419-023-06191-3","volume":"14","author":"R.N. Tian","year":"2023","unstructured":"R.N. Tian et al., RACK1 facilitates breast cancer progression by competitively inhibiting the binding of \u03b2-catenin to PSMD2 and enhancing the stability of \u03b2-catenin. Cell. Death Dis. 14, 685 (2023)","journal-title":"Cell. Death Dis."},{"key":"1161_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13062-024-00488-9","volume":"19","author":"C.Y. Wang","year":"2024","unstructured":"C.Y. Wang et al., C-MYC-activated lncRNA SNHG20 accelerates the proliferation of diffuse large B cell lymphoma via USP14-mediated deubiquitination of \u03b2-catenin. Biol. Direct 19, 47 (2024)","journal-title":"Biol. Direct"},{"key":"1161_CR44","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.7150\/ijbs.98907","volume":"20","author":"Z.D. Xuan","year":"2024","unstructured":"Z.D. Xuan et al., NDR1\/FBXO11 promotes phosphorylation-mediated ubiquitination of \u03b2-catenin to suppress metastasis in prostate cancer. Int J Biol Sci. 20, 4957\u20134977 (2024)","journal-title":"Int J Biol Sci."},{"key":"1161_CR45","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1038\/s41388-024-03141-x","volume":"43","author":"M. Reissland","year":"2024","unstructured":"M. Reissland et al., USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer. Oncogene 43, 3645\u20133659 (2024)","journal-title":"Oncogene"},{"key":"1161_CR46","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ymthe.2025.01.047","volume":"33","author":"J. Shi","year":"2025","unstructured":"J. Shi et al., Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy. Mol. Ther. 33, 1073\u20131090 (2025)","journal-title":"Mol. Ther."},{"key":"1161_CR47","doi-asserted-by":"publisher","first-page":"105443","DOI":"10.1016\/j.phrs.2021.105443","volume":"165","author":"M. Alomari","year":"2021","unstructured":"M. Alomari, TRIM21 - A potential novel therapeutic target in cancer. Pharmacol. Res. 165, 105443 (2021)","journal-title":"Pharmacol. Res."},{"key":"1161_CR48","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.cmet.2023.05.011","volume":"35","author":"X.L. Lu","year":"2023","unstructured":"X.L. Lu et al., UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders. Cell. Metab. 35, 1390\u20131405 (2023)","journal-title":"Cell. Metab."},{"key":"1161_CR49","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ijbiomac.2018.11.269","volume":"124","author":"Y. Jin","year":"2018","unstructured":"Y. Jin et al., TRIM21 mediates ubiquitination of snail and modulates epithelial to mesenchymal transition in breast cancer cells. Int. J. Biol. Macromol. 124, 846\u2013853 (2018)","journal-title":"Int. J. Biol. Macromol."},{"key":"1161_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2021.03.023","volume":"508","author":"X.T. Chen","year":"2021","unstructured":"X.T. Chen et al., Trim21-mediated HIF-1\u03b1 degradation attenuates aerobic glycolysis to inhibit renal cancer tumorigenesis and metastasis. Cancer Lett. 508, 115\u2013126 (2021)","journal-title":"Cancer Lett."},{"key":"1161_CR51","doi-asserted-by":"crossref","unstructured":"M.H. Cao et al., TRIM21-mediated PRMT1 degradation attenuates colorectal cancer malignant progression. Cell. Death Dis. 16(56), (2025)","DOI":"10.1038\/s41419-025-07383-9"},{"key":"1161_CR52","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jcmgh.2021.01.007","volume":"11","author":"F. Wang","year":"2021","unstructured":"F. Wang et al., The ubiquitin E3 ligase TRIM21 promotes hepatocarcinogenesis by suppressing the p62-Keap1-Nrf2 antioxidant pathway. Cell. Mol Gastroenterol Hepatol. 11, 1369\u20131385 (2021)","journal-title":"Cell. Mol Gastroenterol Hepatol."},{"key":"1161_CR53","first-page":"114","volume":"10","author":"Z.P. Zhao","year":"2020","unstructured":"Z.P. Zhao et al., TRIM21 overexpression promotes tumor progression by regulating cell proliferation, cell migration and cell senescence in human glioma. Am J Cancer Res. 10, 114\u2013130 (2020)","journal-title":"Am J Cancer Res."},{"key":"1161_CR54","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.7150\/thno.85662","volume":"13","author":"Y.L. Li","year":"2023","unstructured":"Y.L. Li et al., E3 ubiquitin ligase TRIM21 targets TIF1\u03b3 to regulate \u03b2-catenin signaling in glioblastoma. Theranostics 13, 4919\u20134935 (2023)","journal-title":"Theranostics"},{"key":"1161_CR55","first-page":"55","volume":"42","author":"Z. Zhang","year":"2022","unstructured":"Z. Zhang et al., TRIM21 suppresses invasion of hepatocellular carcinoma cells by promoting \u03b2-catenin ubiquitylation and degradation. Nan Fang Yi Ke Da Xue Xue Bao 42, 55\u201362 (2022)","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01161-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01161-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01161-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:55:19Z","timestamp":1768384519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01161-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1161"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01161-7","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The experiments involving animals were evaluated and authorized by the Experimental Animal Ethics Committee of the Guangdong Second Province General Hospital (Approval No. 2024-DW-KZ-123\u201301). This study was carried out in line with ethical, welfare, and protection principles for animals, as well as national regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"25"}}